EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY 4.0

Glycyrrhizin intake higher than the current international guidelines has no detectable hypermineralocorticoid‐like effect in dogs

Adrian Watson, Elizabeth Fuess, Jeremy Laxalde, Denise Mitchell

Journal of Animal Physiology and Animal Nutrition · 2024

DOI: 10.1111/jpn.14030 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Journal of Animal Physiology and Animal Nutrition, 2024. Verfasst von Adrian Watson und 3 weiteren Autor:innen. Beteiligte Einrichtung: Royal Canin SAS, Aimargues, France. Hauptthemen laut MEDLINE: Glycyrrhizic Acid. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Royal Canin.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glycyrrhizin‐enriched extracts from licorice root are associated with numerous health benefits and are widely used in phytotherapy. There is evidence that ingesting glycyrrhizin beyond threshold concentrations can impact the metabolism of cortisol, inhibiting its conversion to an inactive form, cortisone, via 11‐hydroxysteroid dehydrogenase. A consequence can be a form of hypermineralocorticoidism, with elevated potassium excretion and associated hypertension, as demonstrated in rats and humans. Here, 3 orally dosed concentrations of glycyrrhizin (0.2, 0.4 and 0.6 mg/kg bodyweight/day) were assessed over 28 days in dogs. As the current guidelines reflect a lack of reliable data in this species, our aim was to provide relevant information for doses above the current guidelines. The specific purpose of this study was to demonstrate that an intake of licorice with a known therapeutic benefit to dogs does not cause hypermineralocorticoidism in this species. No changes in blood pressure, nor electrolyte excretion were observed in the dogs given these three glycyrrhizin concentrations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glycyrrhizic AcidAnimalsDogsMaleFemaleMineralocorticoidsDose-Response Relationship, DrugGlycyrrhiza

Stichwörter der Autor:innen

blood pressurecaninehypertensionlicoricenutritionpotassiumrenalsafety

Substanzen

Glycyrrhizic AcidMineralocorticoids

Autor:innen und Institutionen

  • Royal Canin SAS, Aimargues, France.
  • Royal Canin, Pet Health Nutrition Center, Lewisburg, Ohio, USA.

Förderung

  • Royal Canin

Zitieren

APA

Watson, A., Fuess, E., Laxalde, J., & Mitchell, D. (2024). Glycyrrhizin intake higher than the current international guidelines has no detectable hypermineralocorticoid‐like effect in dogs. Journal of Animal Physiology and Animal Nutrition. https://doi.org/10.1111/jpn.14030

Vancouver

Watson A, Fuess E, Laxalde J, Mitchell D. Glycyrrhizin intake higher than the current international guidelines has no detectable hypermineralocorticoid‐like effect in dogs. Journal of Animal Physiology and Animal Nutrition. 2024. doi:10.1111/jpn.14030

BibTeX
@article{Watson2024,
  author = {Watson, Adrian and Fuess, Elizabeth and Laxalde, Jeremy and Mitchell, Denise},
  title = {Glycyrrhizin intake higher than the current international guidelines has no detectable hypermineralocorticoid‐like effect in dogs},
  journal = {Journal of Animal Physiology and Animal Nutrition},
  year = {2024},
  doi = {10.1111/jpn.14030}
}
Kostenlos starten →